Matches in SemOpenAlex for { <https://semopenalex.org/work/W2311211653> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2311211653 endingPage "4" @default.
- W2311211653 startingPage "341" @default.
- W2311211653 abstract "More than ninety percent of bladder neoplasm is Transitional Cell Carcinoma (TCC). About 85% of patients present with symptom of painless haematuria. However haematuria is quite often intermittent so that a negative result has little meaning in ruling out the presence of bladder cancer. The present study was conducted to observe the natural history of different clinicopathologic stages of bladder cancer after transurethral resection bladder tumor (TURBT), either intravescical chemotherapy (IVC) or immunotherapy with BCG and of other forms of therapy like radio-chemotherapy (RCT) and radical surgery in few cases. A consecutive series of 52 cases with different grades and stages of bladder cancer patients were studied. Those who were noncompliant with surgery were sent for RCT. The age range of the patients was 34 to 75 with mean 53 year. Macroscopic haematuria, flank pain, microscopic haematuria, bladder irritability was found in 43(82.7%), 06(11.5%), 03(5.8%), 32(61.5%) cases respectively and coincidental ureteral TCC with hydronephrosis was found in 04(7.7%) cases for whom radical nephreureterectomy and cystectomy with ileal conduit was done. Amongst the other muscle invasive tumor only three cases were compliant to do radical surgery; rest were advised to consult with oncologist for possible RCT. Superficial bladder cancer was 19(36.5%) and invasive bladder cancer was 33(63.5%). TURBT and IVT were offered for all superficial bladder tumors. Of them 06(31.5%) patients showed recurrence during the study period. More recurrences occur in IVC group (35.7%) than immunotherapy with BCG group (20%) Re-TURBT and stage wise treatment was offered to them. All recurrent cases were G-3 tumor and were multifocal. Recurrence rate is about 30%. Screening program and structured referral system should be developed to have early diagnosis for prompt treatment and best prognosis." @default.
- W2311211653 created "2016-06-24" @default.
- W2311211653 creator A5011206589 @default.
- W2311211653 creator A5019958435 @default.
- W2311211653 creator A5024621895 @default.
- W2311211653 creator A5054172723 @default.
- W2311211653 creator A5078900320 @default.
- W2311211653 creator A5081542789 @default.
- W2311211653 date "2014-04-01" @default.
- W2311211653 modified "2023-09-26" @default.
- W2311211653 title "Clinicopathologic features and treatment outcome of urinary bladder neoplasm." @default.
- W2311211653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24858164" @default.
- W2311211653 hasPublicationYear "2014" @default.
- W2311211653 type Work @default.
- W2311211653 sameAs 2311211653 @default.
- W2311211653 citedByCount "0" @default.
- W2311211653 crossrefType "journal-article" @default.
- W2311211653 hasAuthorship W2311211653A5011206589 @default.
- W2311211653 hasAuthorship W2311211653A5019958435 @default.
- W2311211653 hasAuthorship W2311211653A5024621895 @default.
- W2311211653 hasAuthorship W2311211653A5054172723 @default.
- W2311211653 hasAuthorship W2311211653A5078900320 @default.
- W2311211653 hasAuthorship W2311211653A5081542789 @default.
- W2311211653 hasConcept C121608353 @default.
- W2311211653 hasConcept C126322002 @default.
- W2311211653 hasConcept C126894567 @default.
- W2311211653 hasConcept C141071460 @default.
- W2311211653 hasConcept C168563851 @default.
- W2311211653 hasConcept C2775910329 @default.
- W2311211653 hasConcept C2776694085 @default.
- W2311211653 hasConcept C2776874909 @default.
- W2311211653 hasConcept C2778065480 @default.
- W2311211653 hasConcept C2779762690 @default.
- W2311211653 hasConcept C2780352672 @default.
- W2311211653 hasConcept C2781040948 @default.
- W2311211653 hasConcept C71924100 @default.
- W2311211653 hasConcept C77411442 @default.
- W2311211653 hasConceptScore W2311211653C121608353 @default.
- W2311211653 hasConceptScore W2311211653C126322002 @default.
- W2311211653 hasConceptScore W2311211653C126894567 @default.
- W2311211653 hasConceptScore W2311211653C141071460 @default.
- W2311211653 hasConceptScore W2311211653C168563851 @default.
- W2311211653 hasConceptScore W2311211653C2775910329 @default.
- W2311211653 hasConceptScore W2311211653C2776694085 @default.
- W2311211653 hasConceptScore W2311211653C2776874909 @default.
- W2311211653 hasConceptScore W2311211653C2778065480 @default.
- W2311211653 hasConceptScore W2311211653C2779762690 @default.
- W2311211653 hasConceptScore W2311211653C2780352672 @default.
- W2311211653 hasConceptScore W2311211653C2781040948 @default.
- W2311211653 hasConceptScore W2311211653C71924100 @default.
- W2311211653 hasConceptScore W2311211653C77411442 @default.
- W2311211653 hasIssue "2" @default.
- W2311211653 hasLocation W23112116531 @default.
- W2311211653 hasOpenAccess W2311211653 @default.
- W2311211653 hasPrimaryLocation W23112116531 @default.
- W2311211653 hasRelatedWork W1973283217 @default.
- W2311211653 hasRelatedWork W1992071766 @default.
- W2311211653 hasRelatedWork W2001372715 @default.
- W2311211653 hasRelatedWork W2032631414 @default.
- W2311211653 hasRelatedWork W2106811313 @default.
- W2311211653 hasRelatedWork W2311211653 @default.
- W2311211653 hasRelatedWork W2404788961 @default.
- W2311211653 hasRelatedWork W2411124870 @default.
- W2311211653 hasRelatedWork W2441793386 @default.
- W2311211653 hasRelatedWork W3095691676 @default.
- W2311211653 hasVolume "23" @default.
- W2311211653 isParatext "false" @default.
- W2311211653 isRetracted "false" @default.
- W2311211653 magId "2311211653" @default.
- W2311211653 workType "article" @default.